Ginger RAKESTRAW

Person

Somerville, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies binding to vista at acidic pH
- Patent number 12,173,069
- Issue date Dec 24, 2024
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding to vista at acidic pH
- Patent number 12,091,462
- Issue date Sep 17, 2024
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating HLA-E-expressing cancers by administering antib...
- Patent number 12,077,584
- Issue date Sep 3, 2024
- Bristol-Myers Squibb Company
- Natalie Bezman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies and antigen binding peptides for factor XIa inhibitors a...
- Patent number 12,065,505
- Issue date Aug 20, 2024
- Bristol-Myers Squibb Company
- Joseph M. Luettgen
- G01 - MEASURING TESTING
Information Patent Grant
Nucleic acid molecules encoding antibodies which bind natural kille...
- Patent number 11,981,734
- Issue date May 14, 2024
- Bristol-Myers Squibb Company
- Natalie Bezman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,926,673
- Issue date Mar 12, 2024
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind PCSK9
- Patent number 11,858,979
- Issue date Jan 2, 2024
- Bristol-Meyers Squibb Company
- Ray Camphausen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 11,813,315
- Issue date Nov 14, 2023
- Bristol-Myers Squibb Company
- Sharon Cload
- G01 - MEASURING TESTING
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,795,231
- Issue date Oct 24, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,773,178
- Issue date Oct 3, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IP-10 antibodies and their uses
- Patent number 11,708,405
- Issue date Jul 25, 2023
- BRISTOL-MYERS QUIBB COMPANY
- Mohan Srinivasan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding to VISTA at acidic pH
- Patent number 11,603,406
- Issue date Mar 14, 2023
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glypican-3-binding fibronectin based scaffold molecules
- Patent number 11,524,992
- Issue date Dec 13, 2022
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-human natural killer cell inhibitory receptor group 2A protein...
- Patent number 11,274,150
- Issue date Mar 15, 2022
- Bristol-Myers Squibb Company
- Natalie Bezman
- G01 - MEASURING TESTING
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,261,258
- Issue date Mar 1, 2022
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses in treating immune...
- Patent number 11,254,750
- Issue date Feb 22, 2022
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific EGFR/IGFIR binding molecules
- Patent number 10,954,286
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Stuart Emanuel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind PCSK9
- Patent number 10,947,297
- Issue date Mar 16, 2021
- Bristol-Myers Squibb Company
- Ray Camphausen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glypican-3-binding fibronectin based scaffold molecules
- Patent number 10,584,160
- Issue date Mar 10, 2020
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IP-10 antibodies and their uses
- Patent number 10,556,948
- Issue date Feb 11, 2020
- Bristol-Myers Squibb Company
- Mohan Srinivasan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 10,406,212
- Issue date Sep 10, 2019
- Bristol-Myers Squibb Company
- Sharon Cload
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 10,245,302
- Issue date Apr 2, 2019
- Bristol-Myers Squibb Company
- Sharon Cload
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules
- Patent number 10,183,987
- Issue date Jan 22, 2019
- Bristol-Myers Squibb Company
- Stuart Emanuel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind PCSK9
- Patent number 9,856,309
- Issue date Jan 2, 2018
- BRISTOL-MYERS SQUIBB COMPANY
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating cancer by administering EGFR and EGFR/IGFIR bind...
- Patent number 9,771,411
- Issue date Sep 26, 2017
- Bristol-Myers Squibb Company
- Stuart Emanuel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 9,662,373
- Issue date May 30, 2017
- Bristol-Myers Squibb Company
- Sharon Cload
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 9,493,546
- Issue date Nov 15, 2016
- Bristol-Myers Squibb Company
- Sharon Cload
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind PCSK9
- Patent number 9,234,027
- Issue date Jan 12, 2016
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific EGFR/IGFIR binding molecules
- Patent number 9,017,655
- Issue date Apr 28, 2015
- Bristol-Myers Squibb Company
- Stuart Emanuel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 8,993,265
- Issue date Mar 31, 2015
- Bristol-Myers Squibb Company
- Sharon Cload
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
- Publication number 20240316161
- Publication date Sep 26, 2024
- Bristol-Myers Squibb Company
- Sharon CLOAD
- G01 - MEASURING TESTING
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20240239909
- Publication date Jul 18, 2024
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9
- Publication number 20240239870
- Publication date Jul 18, 2024
- Bristol-Myers Squibb Company
- Ray Camphausen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20240124597
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antibodies Binding to VISTA at Acidic pH
- Publication number 20240092907
- Publication date Mar 21, 2024
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20230312686
- Publication date Oct 5, 2023
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST HUMAN TREM-1 AND USES THEREOF
- Publication number 20220332817
- Publication date Oct 20, 2022
- Bristol-Myers Squibb Company
- Achal M. PASHINE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AND ANTIGEN BINDING PEPTIDES FOR FACTOR XIA INHIBITORS A...
- Publication number 20220220220
- Publication date Jul 14, 2022
- Bristol-Myers Squibb Company
- Joseph M. Luettgen
- G01 - MEASURING TESTING
Information Patent Application
ANTI-NKG2A ANTIBODIES AND USES THEREOF
- Publication number 20220204618
- Publication date Jun 30, 2022
- Bristol-Myers Squibb Company
- Natalie Bezman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NKG2A ANTIBODIES AND USES THEREOF
- Publication number 20220195042
- Publication date Jun 23, 2022
- Bristol-Myers Squibb Company
- Natalie Bezman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220169742
- Publication date Jun 2, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220153856
- Publication date May 19, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220144962
- Publication date May 12, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Binding to Vista at Acidic pH
- Publication number 20220073617
- Publication date Mar 10, 2022
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-MERTK ANTIBODIES FOR TREATING CANCER
- Publication number 20210395392
- Publication date Dec 23, 2021
- Bristol-Myers Squibb Company
- Thomas E. Spires
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9
- Publication number 20210277089
- Publication date Sep 9, 2021
- Bristol-Myers Squibb Company
- Ray Camphausen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20210054090
- Publication date Feb 25, 2021
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Binding to Vista at Acidic pH
- Publication number 20210017283
- Publication date Jan 21, 2021
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20200262893
- Publication date Aug 20, 2020
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- G01 - MEASURING TESTING
Information Patent Application
ANTI-NKG2A ANTIBODIES AND USES THEREOF
- Publication number 20200199226
- Publication date Jun 25, 2020
- Bristol-Myers Squibb Company
- Natalie Bezman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IP-10 ANTIBODIES AND THEIR USES
- Publication number 20200190180
- Publication date Jun 18, 2020
- Bristol-Myers Squibb Company
- Mohan SRINIVASAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20200157233
- Publication date May 21, 2020
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies Binding to VISTA at Acidic pH
- Publication number 20200055936
- Publication date Feb 20, 2020
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
- Publication number 20190307855
- Publication date Oct 10, 2019
- Bristol-Myers Squibb Company
- Sharon CLOAD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC EGFR/IGFIR BINDING MOLECULES
- Publication number 20190153069
- Publication date May 23, 2019
- Bristol-Myers Squibb Company
- Stuart EMANUEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20190077844
- Publication date Mar 14, 2019
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9
- Publication number 20180201665
- Publication date Jul 19, 2018
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC EGFR/IGFIR BINDING MOLECULES
- Publication number 20180037631
- Publication date Feb 8, 2018
- Bristol-Myers Squibb Company
- Stuart EMANUEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
- Publication number 20170354718
- Publication date Dec 14, 2017
- Bristol-Myers Squibb Company
- Sharon CLOAD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATE OF AN ANTI-GLYPICAN-3 ANTIBODY AND A TUBULY...
- Publication number 20170326249
- Publication date Nov 16, 2017
- Bristol-Myers Squibb Company
- Chin PAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ginger RAKESTRAW

Person

Patents Grantslast 30 patents

Antibodies binding to vista at acidic pH

Antibodies binding to vista at acidic pH

Methods of treating HLA-E-expressing cancers by administering antib...

Antibodies and antigen binding peptides for factor XIa inhibitors a...

Nucleic acid molecules encoding antibodies which bind natural kille...

Antagonistic CD40 monoclonal antibodies and uses thereof

Fibronectin based scaffold domain proteins that bind PCSK9

Fibronectin based scaffold domain proteins that bind to myostatin

Antagonistic CD40 monoclonal antibodies and uses thereof

Antagonistic CD40 monoclonal antibodies and uses thereof

IP-10 antibodies and their uses

Antibodies binding to VISTA at acidic pH

Glypican-3-binding fibronectin based scaffold molecules

Anti-human natural killer cell inhibitory receptor group 2A protein...

Antagonistic CD40 monoclonal antibodies and uses thereof

Antagonistic CD40 monoclonal antibodies and uses in treating immune...

Bispecific EGFR/IGFIR binding molecules

Fibronectin based scaffold domain proteins that bind PCSK9

Glypican-3-binding fibronectin based scaffold molecules

IP-10 antibodies and their uses

Fibronectin based scaffold domain proteins that bind to myostatin

Fibronectin based scaffold domain proteins that bind to myostatin

Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules

Fibronectin based scaffold domain proteins that bind PCSK9

Method of treating cancer by administering EGFR and EGFR/IGFIR bind...

Fibronectin based scaffold domain proteins that bind to myostatin

Fibronectin based scaffold domain proteins that bind to myostatin

Fibronectin based scaffold domain proteins that bind PCSK9

Bispecific EGFR/IGFIR binding molecules

Fibronectin based scaffold domain proteins that bind to myostatin

Patents Applicationslast 30 patents

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

Antibodies Binding to VISTA at Acidic pH

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

ANTIBODIES AGAINST HUMAN TREM-1 AND USES THEREOF

ANTIBODIES AND ANTIGEN BINDING PEPTIDES FOR FACTOR XIA INHIBITORS A...

ANTI-NKG2A ANTIBODIES AND USES THEREOF

ANTI-NKG2A ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

Antibodies Binding to Vista at Acidic pH

ANTI-MERTK ANTIBODIES FOR TREATING CANCER

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

Antibodies Binding to Vista at Acidic pH

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

ANTI-NKG2A ANTIBODIES AND USES THEREOF

IP-10 ANTIBODIES AND THEIR USES

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

Antibodies Binding to VISTA at Acidic pH

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

BISPECIFIC EGFR/IGFIR BINDING MOLECULES

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9

BISPECIFIC EGFR/IGFIR BINDING MOLECULES

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

ANTIBODY-DRUG CONJUGATE OF AN ANTI-GLYPICAN-3 ANTIBODY AND A TUBULY...